Spire Healthcare Group PLC Agreement signed with the NHS Scotland (4276J)
09 Aprile 2020 - 5:05PM
UK Regulatory
TIDMSPI
RNS Number : 4276J
Spire Healthcare Group PLC
09 April 2020
Spire Healthcare Group plc
("Spire Healthcare", "the Company" or "the Group")
Agreement signed with the NHS Scotland to provide COVID-19
support
9 April 2020
Spire Healthcare (LSE: SPI), a leading UK independent hospital
group, has signed an agreement with NHS Scotland to make the staff,
facilities, equipment and services at its Murrayfield Hospital in
Edinburgh available to the NHS to help in the fight against the
COVID-19 outbreak.
Spire Healthcare will support NHS Scotland with immediate
effect, for an initial period of three months.
Under the agreement, which is similar to those signed in England
and Wales, Spire Healthcare will provide additional capacity,
relieving pressure on NHS hospitals and enabling the NHS to focus
on treating COVID-19 patients.
Ken Hay, Hospital Director at Spire Edinburgh Hospitals, said:
"We are proud that we will be supporting the NHS in every way we
can over the next few months, to tackle this unprecedented global
health crisis."
We are committed to supporting the NHS in combatting the
COVID-19 outbreak and will update the market when further
information is available.
For further information please contact:
Spire Healthcare
Cora McCallum, Head of Investor Relations +44 (0)7967 109 731
Instinctif Partners
Damian Reece +44 (0)7931 598 593
Guy Scarborough +44 (0)7917 178 920
Jeremy Durrant +44 (0)7792 918 648
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare is a leading independent hospital group in the
United Kingdom, with 39 private hospitals and 8 clinics across
England, Wales and Scotland.
Working in partnership with around 7,300 experienced
consultants, Spire Healthcare delivered tailored, personalised care
to approximately 810,000 in-patients and daycase patients in 2019,
and is the leading private provider, by volume, of knee and hip
operations in the United Kingdom.
The Group's well located and scalable hospitals have delivered
successful and award-winning clinical outcomes, positioning the
Group well with patients, consultants, the NHS, GPs and Private
Medical Insurance ("PMI") providers. 85% of Spire Healthcare's
hospitals are rated 'Good' or 'Outstanding' by the CQC (or the
equivalent in Scotland and Wales).
Spire Healthcare treats patients through a variety of routes
including PMI, Self-pay and the NHS, providing the Group with
diversified access to the expected growth opportunities in the UK
healthcare market, which faces significant supply challenges as a
result of NHS budget constraints and increasing demand from a
growing population with longer life expectancy.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
AGRUPURACUPUGCB
(END) Dow Jones Newswires
April 09, 2020 11:05 ET (15:05 GMT)
Grafico Azioni Spire Healthcare (LSE:SPI)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Spire Healthcare (LSE:SPI)
Storico
Da Apr 2023 a Apr 2024